TrialsgrambetaRCTs are beautiful
ESC Congress 2026Presented Sun 30 Aug · 16:45 CESTHot Line 8All Hot Line trials →

NEXAF

2026

The Norwegian Exercise in Atrial Fibrillation Trial

In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.

Result

co-primary: (1) total time in atrial fibrillation (burden, %) measured by insertable cardiac monitor over 12 months; (2) AFEQT overall score at 12 months
Absolute difference
3.2 points
NNT
32
Effect estimate

relative reduction45P = 0.016

Absolute difference and NNT are derived from the event rates.

Also reported: But the co-primary quality-of-life score did not differ (AFEQT +5.6 vs +4.4; P = 0.43). Fitness rose and resting heart rate fell; total hospitalisations were 37% lower and AF-related hospitalisations 46% lower.

Original publication
Subtopic
Exercise
Design
multicentre (Trondheim, Bærum/Drammen, Tromsø), open-label, two-arm RCT; 1:1 supervised plus eHealth-based exercise vs usual care; blinded statistical analysis; 12-month follow-up with insertable cardiac monitor
Relevance
Important: one of several pillars.
Source
Nes BM, et al. Presented at ESC Congress 2026, Hot Line 8, 30 August.

Discussion & critique

Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms, the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.